Compare Baxter International Inc (BAX) vs Freeport-McMoRan Inc (FCX) Price & Performance

Baxter International (BAX) trades at $27.05, down 2.03% today, with a bullish technical signal from moving averages but mixed oscillators. Recent Q2 2026 earnings beat expectations with EPS of $0.56 versus $0.37, and the company raised its 2026 guidance, reflecting operational improvements. However, fundamentals show challenges with a negative net income margin of -9.27% and elevated P/E of 87.85, though revenue trends are stabilizing near $11.5 billion for 2026.

The outlook is cautiously optimistic due to earnings beats and raised guidance, but high valuation and persistent losses pose risks. Analyst consensus is mixed with 42% buy ratings and a $25.43 price target below the current price, suggesting limited upside. Key risks include margin pressure and high debt levels, requiring sustained execution for stock appreciation.

FCX trades at $66.83, down 2.98% on the day, but maintains a bullish technical trend with strong analyst support. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 expected at $0.72 EPS. Revenue remains stable around $25.9B, while net income margin improved to 11.38% in 2026. Recent news highlights operational challenges like lower copper volumes but also growth initiatives at Grasberg and Bagdad.

The outlook is positive with a consensus price target of $73.85, implying ~10% upside. Key opportunities include exposure to high copper prices and expansion projects, while risks involve production volatility, cost pressures, and reliance on commodity cycles. The stock's valuation appears elevated with a P/E of 33.93, requiring sustained earnings growth to justify further gains.